US HB5030 | 2021-2022 | 117th Congress

Status

Spectrum: Strong Partisan Bill (Democrat 51-4)
Status: Introduced on August 13 2021 - 25% progression, died in committee
Action: 2021-08-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To improve diversity in clinical trials and data collection for COVID-19 and future public health threats to address social determinants of health.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

DIVERSE Trials Act Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act

Sponsors


History

DateChamberAction
2021-08-13HouseReferred to the Subcommittee on Health.
2021-08-13HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2021-08-13HouseIntroduced in House

Same As/Similar To

SB2706 (Same As) 2021-08-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4486 (Related) 2022-06-23 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback